Stem cell-derived hepatocytes in co-culture and uses thereof

    公开(公告)号:US10717966B2

    公开(公告)日:2020-07-21

    申请号:US16157930

    申请日:2018-10-11

    Abstract: The present disclosure provides co-cultures of human pluripotent stem cell derived hepatocytes and at least one non-parenchymal cell population in vitro, methods of preparing the co-cultures and methods of using the co-cultures for high throughput screening and evaluation of drug candidates. The stem cell derived hepatocyte co-culture system provides an in vitro model in which cell viability and relatively mature hepatocyte phenotype of stem cell derived hepatocytes are maintained for extended periods relative to conventional monoculture.

    STEM CELL-DERIVED HEPATOCYTES IN CO-CULTURE AND USES THEREOF

    公开(公告)号:US20190048315A1

    公开(公告)日:2019-02-14

    申请号:US16157930

    申请日:2018-10-11

    Abstract: The present disclosure provides co-cultures of human pluripotent stem cell derived hepatocytes and at least one non-parenchymal cell population in vitro, methods of preparing the co-cultures and methods of using the co-cultures for high throughput screening and evaluation of drug candidates. The stem cell derived hepatocyte co-culture system provides an in vitro model in which cell viability and relatively mature hepatocyte phenotype of stem cell derived hepatocytes are maintained for extended periods relative to conventional monoculture.

    STEM CELL-DERIVED HEPATOCYTES IN CO-CULTURE AND USES THEREOF
    6.
    发明申请
    STEM CELL-DERIVED HEPATOCYTES IN CO-CULTURE AND USES THEREOF 审中-公开
    在文化中的干细胞衍生的肝细胞和其用途

    公开(公告)号:US20150240203A1

    公开(公告)日:2015-08-27

    申请号:US14596787

    申请日:2015-01-14

    Abstract: The present disclosure provides co-cultures of human pluripotent stem cell derived hepatocytes and at least one non-parenchymal cell population in vitro, methods of preparing the co-cultures and methods of using the co-cultures for high throughput screening and evaluation of drug candidates. The stem cell derived hepatocyte co-culture system provides an in vitro model in which cell viability and relatively mature hepatocyte phenotype of stem cell derived hepatocytes are maintained for extended periods relative to conventional monoculture.

    Abstract translation: 本公开提供了体外人多能干细胞衍生的肝细胞和至少一种非实质细胞群体的共培养物,制备共培养物的方法和使用共培养物进行高通量筛选和评估候选药物的方法 。 干细胞衍生的肝细胞共培养系统提供了体外模型,其中相对于常规单一培养,干细胞来源的肝细胞的细胞存活力和相对成熟的肝细胞表型保持较长的时间。

Patent Agency Ranking